Cihan Ay: PhD With Distinction in Thrombosis Research in Patients With Primary Brain Tumors
Cihan Ay, Professor of Haematology at Medical University of Vienna, shared on LinkedIn:
“I would like to congratulate Dr. Pegah Mir Seyed Nazari on successfully defending her PhD with distinction this week and completing her MD PhD studies through the MD-PhD Excellence Programme at the Medical University of Vienna!
Dr Nazari´s PhD research focused on thrombosis risk in patients with primary brain tumors and resulted in several interesting and insightful publications, contributing to a better understanding of this frequent complication in patients with brain tumors.
I am very proud of her achievement of completing this important milestone. I wish her every success in her future career and all the very best for the journey ahead!”
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 15:50M Velia Antonini: ECMO Cannula Design and Its Impact on Blood Flow, Thrombosis and Hemolysis
-
Oct 10, 2026, 15:07Khalid Ahmed: Mortality and Survival in Young People With Sickle Cell Disease and Beta Thalassaemia in England 1997 to 2025
-
Oct 10, 2026, 14:59Matteo Foschi: Antithrombotic Therapy in Secondary Stroke Prevention 10 Clinical Pearls Every Clinician Should Know
-
Oct 10, 2026, 14:33Ahmad Gharehbaghian: Supporting Blood Transfusion Teams and Strengthening Iran’s Blood Supply
-
Oct 10, 2026, 14:17Caitlin Raymond: Long-Term Infection Risk With ECP in GVHD
-
Oct 10, 2026, 14:09Emmanuel J Favaloro: 100 years of von Willebrand Disease in 2026
-
Oct 10, 2026, 13:54WFH Strengthens Collaboration to Advance Hemophilia Care in Paraguay
-
Oct 10, 2026, 13:40Shayan Mohammadmoradi: Platelets as Stress Sensors A New Perspective on Platelet Biology
-
Oct 10, 2026, 13:32Edward Lee Carter: When Normal Ferritin Does Not Rule Out Iron Deficiency